Aptevo Therapeutics Inc (APVO)
0.5918
-0.18
(-22.91%)
USD |
NASDAQ |
Jun 17, 16:00
0.5918
0.00 (0.00%)
After-Hours: 19:42
Aptevo Therapeutics Enterprise Value: -7.118M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 14, 2024 | -7.118M |
| June 13, 2024 | -7.063M |
| June 12, 2024 | -6.869M |
| June 11, 2024 | -6.831M |
| June 10, 2024 | -6.863M |
| June 07, 2024 | -7.022M |
| June 06, 2024 | -6.79M |
| June 05, 2024 | -6.864M |
| June 04, 2024 | -6.965M |
| June 03, 2024 | -7.035M |
| May 31, 2024 | -7.342M |
| May 30, 2024 | -7.290M |
| May 29, 2024 | -7.272M |
| May 28, 2024 | -7.276M |
| May 24, 2024 | -7.349M |
| May 23, 2024 | -7.272M |
| May 22, 2024 | -7.186M |
| May 21, 2024 | -7.067M |
| May 20, 2024 | -7.214M |
| May 17, 2024 | -6.986M |
| May 16, 2024 | -7.001M |
| May 15, 2024 | -6.953M |
| May 14, 2024 | -6.872M |
| May 13, 2024 | -6.937M |
| May 10, 2024 | -6.619M |
| Date | Value |
|---|---|
| May 09, 2024 | -6.435M |
| May 08, 2024 | -6.068M |
| May 07, 2024 | -6.081M |
| May 06, 2024 | -6.260M |
| May 03, 2024 | -6.695M |
| May 02, 2024 | -6.189M |
| May 01, 2024 | -6.800M |
| April 30, 2024 | -7.696M |
| April 29, 2024 | -7.555M |
| April 26, 2024 | -7.712M |
| April 25, 2024 | -7.806M |
| April 24, 2024 | -7.797M |
| April 23, 2024 | -7.604M |
| April 22, 2024 | -7.698M |
| April 19, 2024 | -7.636M |
| April 18, 2024 | -7.482M |
| April 17, 2024 | -7.689M |
| April 16, 2024 | -9.016M |
| April 15, 2024 | -8.992M |
| April 12, 2024 | -9.675M |
| April 11, 2024 | -9.598M |
| April 10, 2024 | -8.634M |
| April 09, 2024 | -8.055M |
| April 08, 2024 | -7.745M |
| April 05, 2024 | -7.806M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-17.43M
Minimum
Sep 25 2023
200.70M
Maximum
Nov 11 2020
20.93M
Average
1.644M
Median
Enterprise Value Benchmarks
| Johnson & Johnson | 357.68B |
| BioSig Technologies Inc | 5.725M |
| Adial Pharmaceuticals Inc | 0.5205M |
| IN8bio Inc | 35.08M |
| NovaBay Pharmaceuticals Inc | 3.382M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.834M |
| Total Expenses (Quarterly) | 6.983M |
| EPS Diluted (Quarterly) | -9.95 |
| Earnings Yield | -16.80K% |
| Normalized Earnings Yield | -45748.13 |